跳至主要内容

Pharmaceutical Development Services

 Medicilon has been offering high quality analytical testing services to the pharmaceutical industry for decades. We offer a wide range of quality control testing services to support drug research, registration and production. Biopharmaceutical companies also use many of the same services and Medicilon has also added new services to accommodate their unique needs (detailed in the following section).

We perform a variety of tests that are client-specific, particularly in the area of analytical chemistry. Please inquire for more information about additional tests we perform that may not be listed in this brochure.



Laboratory Services

GLP and GCP Bioanalytical Services & Biomarkers
GMP and CMC Laboratory Services
Pharmaceutical Analysis, Stability and Formulation Development Extractables/Leachables Packaging Support
Process Development and Manufacturing Analysis Support

Bioanalytical Services

Our teams are adept in method development,method validation and transfer of efficient and accurate methods which are optimized for your compound. Projects are assigned to and managed by experienced Principal Investigators with support from teams of Project Managers, Project Coordinators, Senior Scientists and Chemists. We provide:

• Bioanalysis for Large and Small Molecules
• Immunogenicity & Neutralizing Antibody Assays
• Antibody Drug Conjugate (ADC) LC-MS and Immunochemistry Services
• Long History of Bioanalytical Support for Biosimilar Drug Development
• Post Marketing Antidrug Antibody (ADA) assays
• Demonstrated Expertise in Ocular Tissue

GMP and Chemistry, Manufacturing & Controls (CMC) Laboratory Services

• GMP Pharmaceutical Analysis
• Method Development & Validation
• Biopharmaceutical CMC Solutions
• GMP Stability Studies
• GMP Batch Release Testing
• Extractables / Leachables
• Glass Delamination Studies
• Elemental Impurities
• Formulation Development
• Preformulation and Physical Characterisation
• GMP Quality Control Testing
• Reference Standard Certification
• Impurities and Particulates Analysis
• Clinical Trial Supplies Manufacturing Services
• Regulatory Affairs
• GMP Auditing and Supply Chain Assurance
• GMP Training Sessions and eLearning For Staff

ANALYTICAL CHEMISTRY
Medicilon provides the professional expertise and regulatory qualifications necessary to perform analytical testing of raw materials, APIs, finished products, packaging material and medical devices. Well-equipped state-of-the-art laboratories offer comprehensive testing services according to the pharmacopoeia and to customer specifications.

STABILITY STUDIES
With a network of ICH stability storage facilities, we offer an extensive capacity and a range of conditions including climatic walk-in chambers and cabinets as well as freezer storage. Our stability teams provide professionally managed cGMP stability programs for even the most complex of dosage forms including orally inhaled and nasal drug products (OINDP), biopharmaceuticals, medical devices or vaccines.

PREFORMULATION
Our team of chemical and formulation development scientists work together to fully understand the physiochemical properties of your drug substance prior to formulating an optimum drug product for clinical supplies, using:

• Polymorph Screening, Crystal Engineering & Crystal Form Selection
• Physiochemical Characterization of API
• Excipient Compatibility Studies

NON-GMP DEVELOPMENT

Our non-GMP development services offer you greater flexibility and speed. With a state of-the-art facility, we are able to focus on lab-scale experiments with batch sizes ranging from <1kg up to approximately 5kg scale for most technologies.

With both our non-GMP and GMP facilities residing on the same campus, we can provide a seamless transition between the development and GMP phases of projects in early stage development.

Biopharmaceutical Services

Our thought-leaders have over 12 years of experience in biopharmaceutical development support across a wide range of product types. Our experts provide regulatory led, phase-appropriate, tailored analytical program design and GLP or GMP compliant laboratory services which help you to navigate the challenges of development, regulatory submission and manufacturing.

Biopharmaceutical Development Support

• GLP Preclinical Bioanalysis
• Immunogenicity Studies
• Analytical Program Design
• Structural Characterization (ICH Q6B)
• Physicochemical Properties (ICH Q6B)
• Comparability Studies
• Biosimilar Programes
• Process Residuals Determination
• Product Related Impurities Determination
• Aggregation Studies
• GMP Potency / Cell Based Assays
• Method Development & Validation
• Extractables / Leachables
• GMP Quality Control Testing
• GMP Batch & Final Product Release Testing
• ICH Stability Studies
• Forced Degradation Studies

• Drug Delivery / OINDP Expertise

Contact Us 

Email : marketing@medicilon.com

Tel : +44 1223 981 792（Europe）

+82 (0)70-8269-5849（South Korea）

08044216898（Japan）

+86 021 58591500（China )

Website: https://www.medicilon.com

 

Tips : Above is part of pharmaceutical development services, pharmaceutical product development, pharmaceutical development. You can also CONTACT US with any question or enquiry you may have. We will be happy to discuss your needs in detail and design an appropriate plan of action.

Related Articles:

Pharmaceutical Preformulation Studies

标签：

评论

发表评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...
发表评论
阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...
发表评论
阅读全文

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...
发表评论
阅读全文